- Q4 2024 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2024₹1032.3 (+0.28%)Earnings
- Q3 2024 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2024₹887.1 (+0.26%)Earnings
- Q2 2024 Natco Pharma Ltd Earnings Call TranscriptNov 15, 2023₹758.65 (-4.48%)Earnings
- Natco Pharma Ltd Annual Shareholders Meeting TranscriptSep 29, 2023
- Q1 2024 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2023₹876.05 (-1.97%)Earnings
- Q4 2023 Natco Pharma Ltd Earnings Call TranscriptMay 30, 2023₹619.5 (-2.15%)Earnings
- Q3 2023 Natco Pharma Ltd Earnings Call TranscriptFeb 10, 2023₹524.85 (-0.88%)Earnings
- Q2 2023 Natco Pharma Ltd Earnings Call TranscriptNov 11, 2022₹584 (-0.72%)Earnings
- Q1 2023 Natco Pharma Ltd Earnings Call TranscriptAug 10, 2022₹672.85 (-10.35%)Earnings
- Q4 2022 Natco Pharma Ltd Earnings Call TranscriptMay 31, 2022₹690.95 (+3.72%)Earnings
- Q3 2022 Natco Pharma Ltd Earnings Call TranscriptFeb 15, 2022₹895.35 (-2.40%)Earnings
- Q2 2022 Natco Pharma Ltd Earnings Call TranscriptNov 12, 2021₹828.7 (+0.55%)Earnings
- Q1 2022 Natco Pharma Ltd Earnings Call TranscriptAug 12, 2021₹1041.45 (+3.06%)Earnings
- Q4 2021 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2021₹1095.8 (+1.25%)Earnings
- Q3 2021 Natco Pharma Ltd Earnings Call TranscriptFeb 12, 2021₹854 (-3.64%)Earnings
- Q2 2021 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2020₹900.9 (-0.63%)Earnings
- Q1 2021 Natco Pharma Ltd Earnings Call TranscriptAug 13, 2020₹813.4 (-4.17%)Earnings
- Q4 2020 Natco Pharma Ltd Earnings Call TranscriptJun 18, 2020₹620.05 (+0.99%)Earnings
- Q3 2020 Natco Pharma Ltd Earnings Call TranscriptFeb 13, 2020₹673.95 (-4.91%)Earnings
- Q2 2020 Natco Pharma Ltd Earnings Call TranscriptNov 13, 2019₹560.15 (-3.19%)Earnings
- Q1 2020 Natco Pharma Ltd Earnings Call TranscriptAug 09, 2019₹551.45 (-0.27%)Earnings
- Q4 2019 Natco Pharma Ltd Earnings Call TranscriptMay 28, 2019₹529.9 (+0.94%)Earnings
Q3 2020 Natco Pharma Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q3 FY '20 Earnings Conference Call of NATCO Pharma Limited hosted by Axis Capital Limited. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Prakash Agarwal from Axis Capital. Thank you. And over to you, sir.
Yes, thanks. I welcome you all on behalf of Axis Capital to the Q3 Fiscal '20 NATCO Conference Call, represented by senior management team, Mr. Rajeev Nannapaneni, Vice Chairman and Chief Executive Officer; and Mr. Rajesh Chebiyam, Vice President, Acquisitions, Institutional Investor Management and Corporate Communications.
Over to you, Rajesh.
Thank you, Prakash. Good morning, and welcome everyone to NATCO's conference call discussing our earnings results for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)